Delivery Order SPE2DB22D2007-SPE2DB25FH8TW
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,066.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML infusion bottles, a medical product. The contract has an ultimate completion date of January 15, 2025 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $5,006.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, to support the agency's medical supply needs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.68, is a Firm Fixed Price Delivery Order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. In addition to this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,053.00 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product used in healthcare settings. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.52 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of October 28, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,675.60 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,171.42 fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,845.73 Firm Fixed Price Delivery Order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, to support military treatment facilities and programs. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,265.73, is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,118.34 firm-fixed-price delivery order is for the supply of VISIPAQUE 320 mg/ml bottles of 100 ml. The award is not associated with a set-aside program. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, through its Corporate Office division, is a significant supplier of prescription medications, over-the-counter...